BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27007263)

  • 1. Optic pathway glioma in children: 10 years of experience in a single institution.
    Doganis D; Pourtsidis A; Tsakiris K; Baka M; Kouri A; Bouhoutsou D; Varvoutsi M; Servitzoglou M; Dana H; Kosmidis H
    Pediatr Hematol Oncol; 2016 Mar; 33(2):102-8. PubMed ID: 27007263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
    Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
    Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
    Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and Outcome in 65 Children with Optic Pathway Gliomas.
    El Beltagy MA; Reda M; Enayet A; Zaghloul MS; Awad M; Zekri W; Taha H; El-Khateeb N
    World Neurosurg; 2016 May; 89():525-34. PubMed ID: 26898488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
    Ullrich NJ; Prabhu SP; Packer RJ; Goldman S; Robison NJ; Allen JC; Viskochil DH; Gutmann DH; Perentesis JP; Korf BR; Fisher MJ; Kieran MW;
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28833. PubMed ID: 33336845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C; Aharoni S; Halevy A
    Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
    Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
    Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
    Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
    Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.